SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 1st, 2017 • Rennova Health, Inc. • Services-testing laboratories • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of August 31, 2017, between Rennova Health, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
EXCHANGE AGREEMENTExchange Agreement • September 1st, 2017 • Rennova Health, Inc. • Services-testing laboratories • New York
WHEREAS, on July 16, 2017, pursuant to that certain Securities Purchase Agreement, by and among the Company and the investors signatory thereto, dated as of July 16, 2017 (the “Purchase Agreement”), the Company issued to the Investor (i) an unregistered Original Issue Discount Debenture with an aggregate principal amount equal to $______ (the “July Debenture”) (ii) an unregistered Original Issue Discount Debenture with an aggregate principal amount equal to $________, in exchange for an unregistered Original Issue Discount Debenture with an aggregate principal amount equal to $________ originally issued on June 22, 2017 (the “June I Debenture”) and (iii) an unregistered Original Issue Discount Debenture with an aggregate principal amount equal to $________, in exchange for an unregistered Original Issue Discount Debenture with an aggregate principal amount equal to $________ originally issued on June 2, 2017 (the “June II Debenture” and collectively with the July Debenture and the June
